Sally Tan

466 total citations
19 papers, 331 citations indexed

About

Sally Tan is a scholar working on Oncology, Dermatology and Epidemiology. According to data from OpenAlex, Sally Tan has authored 19 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Dermatology and 5 papers in Epidemiology. Recurrent topics in Sally Tan's work include Cutaneous Melanoma Detection and Management (4 papers), Nail Diseases and Treatments (2 papers) and Autoimmune Bullous Skin Diseases (2 papers). Sally Tan is often cited by papers focused on Cutaneous Melanoma Detection and Management (4 papers), Nail Diseases and Treatments (2 papers) and Autoimmune Bullous Skin Diseases (2 papers). Sally Tan collaborates with scholars based in United States, Canada and Singapore. Sally Tan's co-authors include Arash Mostaghimi, Kira Seiger, Jonathan Fisher, Jeremy Y. Feng, Cara Joyce, Elizabeth A. Buzney, Sara M. Tolaney, Eric P. Winer, William T. Barry and Nicole R. LeBoeuf and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Pediatrics and Journal of the American Academy of Dermatology.

In The Last Decade

Sally Tan

17 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sally Tan United States 10 97 51 50 47 43 19 331
Florina Constantinescu United States 12 52 0.5× 23 0.5× 45 0.9× 34 0.7× 44 1.0× 22 494
Janna Manjelievskaia United States 12 103 1.1× 18 0.4× 67 1.3× 27 0.6× 53 1.2× 39 420
Ana I. Velázquez United States 9 173 1.8× 30 0.6× 55 1.1× 41 0.9× 25 0.6× 50 332
Wenjuan He China 7 267 2.8× 30 0.6× 52 1.0× 17 0.4× 37 0.9× 14 513
Wendy Vogel United States 8 83 0.9× 21 0.4× 30 0.6× 34 0.7× 26 0.6× 17 279
Jingbo Yu United States 11 333 3.4× 49 1.0× 52 1.0× 31 0.7× 52 1.2× 18 533
E De Cock United Kingdom 15 172 1.8× 14 0.3× 61 1.2× 86 1.8× 36 0.8× 50 571
Diana Sun United States 11 85 0.9× 29 0.6× 38 0.8× 65 1.4× 127 3.0× 34 600
Julia Lai‐Kwon Australia 12 275 2.8× 23 0.5× 78 1.6× 46 1.0× 53 1.2× 47 418
Chunhuan Lao New Zealand 11 188 1.9× 11 0.2× 83 1.7× 42 0.9× 66 1.5× 57 399

Countries citing papers authored by Sally Tan

Since Specialization
Citations

This map shows the geographic impact of Sally Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Tan more than expected).

Fields of papers citing papers by Sally Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Tan. The network helps show where Sally Tan may publish in the future.

Co-authorship network of co-authors of Sally Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Tan. A scholar is included among the top collaborators of Sally Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Tan. Sally Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Merola, Joseph F., et al.. (2025). Defining “Flares” in Atopic Dermatitis: A Narrative Review. American Journal of Clinical Dermatology. 26(6). 905–921.
2.
Lee, Daniela, et al.. (2024). Surgical Site Allergic Contact Dermatitis Due to 2-Octyl Cyanoacrylate: A Systematic Review and FDA MAUDE Review. Aesthetic Surgery Journal. 45(4). NP119–NP125.
3.
Tan, Sally, et al.. (2022). Deep cutaneous candidiasis of the lip in a patient with acute myelogenous leukemia. JAAD Case Reports. 27. 32–34. 1 indexed citations
4.
Tan, Sally, et al.. (2021). Toxic epidermal necrolysis-like toxic erythema of chemotherapy: 2 illustrative cases. JAAD Case Reports. 15. 56–59. 4 indexed citations
5.
Tan, Sally, et al.. (2020). DiPODS: A Reagent for Site-Specific Bioconjugation via the Irreversible Rebridging of Disulfide Linkages. Bioconjugate Chemistry. 31(12). 2789–2806. 18 indexed citations
6.
Tan, Sally, Jeremy Y. Feng, Cara Joyce, Jonathan Fisher, & Arash Mostaghimi. (2020). Association of Hospital Discharge Against Medical Advice With Readmission and In-Hospital Mortality. JAMA Network Open. 3(6). e206009–e206009. 61 indexed citations
7.
Singer, Sean, Sally Tan, Anna K. Dewan, et al.. (2019). Cutaneous eruptions from ibrutinib resembling epidermal growth factor receptor inhibitor–induced dermatologic adverse events. Journal of the American Academy of Dermatology. 88(6). 1271–1281. 26 indexed citations
8.
Leone, José Pablo, Dan G. Duda, Jiani Hu, et al.. (2019). A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastases. Breast Cancer Research and Treatment. 179(1). 113–123. 31 indexed citations
9.
Tan, Sally, et al.. (2019). Trends in Private Equity Acquisition of Dermatology Practices in the United States. JAMA Dermatology. 155(9). 1013–1013. 65 indexed citations
10.
Fisher, Jonathan, Jeremy Y. Feng, Sally Tan, & Arash Mostaghimi. (2019). Analysis of Readmissions Following Hospitalization for Cellulitis in the United States. JAMA Dermatology. 155(6). 720–720. 8 indexed citations
12.
Aeschlimann, Florence A., et al.. (2018). Risk of Serious Infections Associated with Biologic Agents in Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analyses. The Journal of Pediatrics. 204. 162–171.e3. 14 indexed citations
13.
Tan, Sally, Elizabeth A. Buzney, & Arash Mostaghimi. (2018). Trends in phototherapy utilization among Medicare beneficiaries in the United States, 2000 to 2015. Journal of the American Academy of Dermatology. 79(4). 672–679. 20 indexed citations
14.
Tan, Sally, Julie Najita, Xiaoxue Li, et al.. (2018). Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients. Melanoma Research. 29(1). 70–76. 8 indexed citations
15.
Tan, Sally, Daphne Tsoucas, & Arash Mostaghimi. (2017). Association of Dermatologist Density With the Volume and Costs of Dermatology Procedures Among Medicare Beneficiaries. JAMA Dermatology. 154(1). 73–73. 11 indexed citations
16.
Tan, Sally & Maryanne M. Senna. (2017). Hair and Nail Manifestations of Systemic Disease. Current Dermatology Reports. 6(1). 17–28. 3 indexed citations
17.
Tolaney, Sara M., Sally Tan, Hao Guo, et al.. (2015). Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer. Investigational New Drugs. 33(5). 1108–1114. 47 indexed citations
18.
Kim, Caroline C., Julie Najita, Sally Tan, et al.. (2015). Factors associated with worse outcome for patients with AJCC stage IIC relative to stage IIIA melanoma.. Journal of Clinical Oncology. 33(15_suppl). 9078–9078. 1 indexed citations
19.
Chow, Pierce K. H., et al.. (2000). Changes in prostaglandin and nitric oxide levels in the hyperdynamic circulation following liver resection. Journal of Gastroenterology and Hepatology. 15(8). 895–901. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026